Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Nevro Corp (NVRO – Research Report), Globus ...

Globus Medical, Inc. GMED continues to benefit from ... Globus is also optimistic about the recently inked deal to acquire Nevro Corporation. The acquisition of Nevro is expected to expand Globus ...

Wells Fargo analyst Nathan Treybeck maintained a Hold rating on Nevro Corp yesterday and set ... a Moderate Buy analyst consensus rating for Globus Medical with a $98.75 average price target ...

Globus Medical, Inc. GMED continues to benefit from the robust demand for its Musculoskeletal Solutions products. Following the NuVasive merger, the combined company has formed a global ...

Globus Medical currently awaits a strong cadence of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.

2025 Financial Guidance and Fourth-Quarter 2024 Earnings Conference Call and Webcast As previously announced on February 6, 2025, given the pending acquisition of Nevro by Globus Medical ...

Several spine and orthopedic companies have made progress with acquisitions in the first quarter of 2025. 1. Stryker has ...

Fourth-Quarter 2024 Business Highlights and Recent Developments On February 6, 2025, Nevro and Globus Medical (NYSE: GMED ) announced that they had entered into a definitive agreement for Globus ...